Number	Group
50	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
37	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
27	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Commentary on the protection concept: Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

VA Arzneitherapiesicherheit

07.06.2022

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
Mitglied im hausinternen Cirs-Team

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL08 - Editors of scientific journals/textbooks

Explanation

FL04 - Project-related cooperation with colleges and universities

Explanation

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Teilnahme an Hauptvorlesungen, fakultatives Lehrangebot Chirurgie, Gefäßchirurgie an der Charité

FL05 - Participation in multi-centre Phase I/II studies

Explanation

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

HB17 - Auxiliary nurse (m/f)

Comment

HB19 - Nursing professionals

Comment

HB07 - Surgical technical assistant (m/f)

Comment

Praxiseinrichtung

HB18 - Emergency paramedics (m/f) (training period 3 years)

Comment

Praxiseinrichtung

HB21 - Geriatric nurse (m/f)

Comment

Praxiseinrichtung

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 9
- Additional staff: 7
- Nursing staff regulation

Service contact persons

Patient advocates

Annemarie Tasche

Patientenfürsprecherin

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3029
Mail: ed.nilreb-suksiznarf@ofni

seit März 2020 Joachim Brunner

Patientenfürsprecher

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3029
Mail: ed.nilreb-suksiznarf@ofni

Joachim Brunner

Patientenfürsprecher

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-5240
Mail: ed.nilreb-suksiznarf@rehcerpsreufnetneitap

Customer feedback management

Marlen Isendahl

Zentrales Qualitätsmanagement

Budapester Str. 15-19
10787 Berlin

Phone: 030 -7882-2141
Mail: ed.kjs@lhadnesi.nelram

Christian Mühlig

Zentrales Qualitätsmanagement

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3015
Mail: ed.nilreb-suksiznarf@gilheum.naitsirhc

Christian Mühlig

Zentrales Qualitätsmanagement

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3015
Mail: ed.nilreb-suksiznarf@gilheum.naitsirhc

Quality management

Jörg Niemann

Qualitätsmanagementbeauftragter

Budapester Str. 15-19
10787 Berlin

Phone: 030 -7882-2075
Mail: ed.kjs@nnamein.greoj

Jörg Niemann

Qualitätsmanagementbeauftragter

Budapester Str. 15-19
10787 Berlin

Phone: 030 -7882-2075
Mail: ed.kjs@nnamein.greoj

Hygiene officer

Dr. med. Achim Foer

Ärztlicher Direktor, Chefarzt Klinik für Anästhesiologie

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-6144
Mail: ed.nilreb-suksiznarf@reof.mihca

Dr. med. Achim Foer

Ärztlicher Direktor, Chefarzt Klinik für Anästhesiologie

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-6144
Mail: ed.nilreb-suksiznarf@reof.mihca

Responsible for drug therapy

MBA Elke Dechandt

Leitung der Zentralapotheke

Budapester Str. 15-19
10787 Berlin

Phone: 030 -3035-4700
Mail: ed.nilreb-nekinilk-krd@tdnahced.e

MBA Elke Dechandt

Leitung der Zentralapotheke

Budapester Str. 15-19
10787 Berlin

Phone: 030 -7882-5260
Mail: ed.kjs@tdnahced.ekle

Accessibility Officer

Dieter Seiring

Leitung Allgemeine Patientenverwaltung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3009
Mail: ed.nilreb-suksiznarf@gniries.reteid

Dieter Seiring

Leitung Allgemeine Patientenverwaltung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3009
Mail: ed.nilreb-suksiznarf@gniries.reteid

Company

General contact details of the hospital

Budapester Str. 15-19
10787 Berlin

Phone: 030-2638-0
Fax: 030-2638-3017
Mail: ed.nilreb-suksiznarf@ofni

Nursing service management

Pahl Sebastian

Pflegerische Standortleitung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-6185
Mail: ed.nilreb-suksiznarf@lhap.naitsabes

Dipl. Pflegewirt Tino Hortig

Pflegedirektor

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3003
Mail: ed.nilreb-suksiznarf@gitroh.onit

Pahl Sebastian

Pflegerische Standortleitung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-6185
Mail: ed.nilreb-suksiznarf@lhap.naitsabes

Dipl. Pflegewirt Tino Hortig

Pflegedirektor

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3003
Mail: ed.nilreb-suksiznarf@gitroh.onit

Head of administration

Sr. M. Emanuele Mansfeld

Krankenhausoberin

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3006
Mail: ed.nilreb-suksiznarf@eleuname.rs

Dipl. Betriebswirt Tobias Dreißigacker

Kaufmännischer Direktor

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3011
Mail: ed.nilreb-suksiznarf@rekcagissierd.saibot

Matthias Schwarz

Kaufmännische Leitung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3010
Mail: ed.nilreb-suksiznarf@zrawhcs.saihttam

Sr. M. Emanuele Mansfeld

Krankenhausoberin

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3006
Mail: ed.nilreb-suksiznarf@eleuname.rs

Dipl. Betriebswirt Tobias Dreißigacker

Kaufmännischer Direktor

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3011
Mail: ed.nilreb-suksiznarf@rekcagissierd.saibot

Matthias Schwarz

Kaufmännische Leitung

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3010
Mail: ed.nilreb-suksiznarf@zrawhcs.saihttam

Responsible for the quality report in the hospital management

Dipl. Betriebswirt Tobias Dreißigacker

Geschäftsführer

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3011
Mail: ed.kjs@rekcagissierd.saibot

Dipl. Betriebswirt Tobias Dreißigacker

Geschäftsführer

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3011
Mail: ed.kjs@rekcagissierd.saibot

Medical management

Dr. Achim Foer

Ärztlicher Direktor, Chefarzt der Klinik für Anästhesiologie

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3500
Mail: ed.nilreb-suksiznarf@reof.mihca

Dr. Achim Foer

Ärztlicher Direktor, Chefarzt der Klinik für Anästhesiologie

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3500
Mail: ed.nilreb-suksiznarf@reof.mihca

PD Dr. Carsten Kempkensteffen

Ärztlicher Direktor (seit 2023), Chefarzt Klinik für Urologie

Budapester Str. 15-19
10787 Berlin

Phone: 030 -2638-3814
Mail: ed.nilreb-suksiznarf@eigoloru

Regional care obligation for psychiatry?

IK number

IK: 261100036

Location number

Location number: 771918000

Old location number: 771918000